Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$160.99 - $215.69 $342,264 - $458,556
2,126 New
2,126 $405,000
Q2 2023

Aug 14, 2023

SELL
$223.05 - $302.68 $14.5 Million - $19.7 Million
-64,939 Reduced 77.4%
18,964 $5.41 Million
Q1 2023

May 15, 2023

SELL
$175.41 - $217.92 $14.8 Million - $18.4 Million
-84,420 Reduced 50.15%
83,903 $18.2 Million
Q4 2022

Feb 14, 2023

SELL
$204.38 - $296.82 $4.4 Million - $6.39 Million
-21,545 Reduced 11.35%
168,323 $34.6 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $30.7 Million - $48.8 Million
157,013 Added 477.9%
189,868 $52.8 Million
Q2 2022

Aug 15, 2022

SELL
$115.91 - $214.48 $4.08 Million - $7.55 Million
-35,220 Reduced 51.74%
32,855 $6.28 Million
Q1 2022

May 16, 2022

SELL
$127.96 - $207.36 $1.92 Million - $3.11 Million
-14,997 Reduced 18.05%
68,075 $14.1 Million
Q4 2021

Feb 14, 2022

SELL
$165.13 - $241.83 $4.6 Million - $6.74 Million
-27,886 Reduced 25.13%
83,072 $14.8 Million
Q3 2021

Nov 15, 2021

BUY
$163.99 - $235.57 $6.03 Million - $8.66 Million
36,766 Added 49.56%
110,958 $22.8 Million
Q2 2021

Aug 16, 2021

BUY
$131.45 - $201.49 $975,490 - $1.5 Million
7,421 Added 11.11%
74,192 $14.1 Million
Q1 2021

May 17, 2021

SELL
$92.73 - $142.05 $2.91 Million - $4.46 Million
-31,368 Reduced 31.96%
66,771 $8.7 Million
Q4 2020

Feb 16, 2021

BUY
$67.44 - $103.72 $1.19 Million - $1.83 Million
17,610 Added 21.87%
98,139 $10.2 Million
Q3 2020

Nov 16, 2020

BUY
$42.79 - $75.8 $3.45 Million - $6.1 Million
80,529 New
80,529 $6.1 Million
Q4 2019

Feb 14, 2020

SELL
$29.4 - $44.98 $1.57 Million - $2.4 Million
-53,333 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$29.71 - $55.23 $1.58 Million - $2.95 Million
53,333 New
53,333 $1.6 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.